{"id":"fb30044a33d1","type":"article","url":"https://hartvaat.nl/2023/04/01/aspirine-in-primaire-preventie-en-hartfalenrisico-meta-analyse/","title":"Aspirine in primaire preventie en hartfalenrisico: meta-analyse","title_en":"Aspirin in primary prevention and the risk of heart failure: a systematic review and meta-analysis of controlled trials.","category":"hartfalen","category_label":"Hartfalen","professions":["cardioloog","huisarts"],"tags":["aspirine","primaire-preventie"],"journal":"ESC heart failure","doi":"10.1002/ehf2.14269","source_url":"https://doi.org/10.1002/ehf2.14269","authors":["Ana Beatrice Magalhães de Oliveira","Beatriz Luchiari","Isabella Bonilha","Joaquim Barreto","Ana Claudia Cavalcante Nogueira","Guilherme Duprat Ceniccola","Carisi Anne Polanczyk","Andrei Carvalho Sposito","Luiz Sérgio Fernandes de Carvalho"],"significance":5,"published":"2023-04-01","source_date":"2023-04-01","image":"","kennis":[],"congress":"","summary_en":"This meta-analysis found that aspirin in primary prevention does not significantly increase or decrease the risk of heart failure, clarifying a neutral relationship between aspirin and HF development.","created":"2026-07-03T10:30:18Z","updated":"2026-07-03T13:29:22Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Meta-analyse onderzocht of aspirine in primaire preventie het risico op hartfalen beïnvloedt. De resultaten waren neutraal: aspirine verlaagde noch verhoogde het hartfalenrisico significant, wat aspirine geen rol geeft in hartfalenpreventie.","abstract_original":""}